跳至主要内容
临床试验/NCT00875290
NCT00875290Unknown3 期

Gerber Pump Trial: Effectiveness of Continuous Subcutaneous Insulin Infusion (CSII) and Real-Time Sensor Augmentation (RTSA) in 0-3 Years Old Diabetes Patients; A One Year Randomized Controlled Clinical Trial.

Seattle Children's Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
3 期
入组人数
40
试验地点
2
主要终点
Reduce blood glucose variability among 0-3 year old children with type I diabetes.

研究概览

简要总结

The purpose of this study is to see if the use of a real-time glucose sensor improves diabetes control in young children (less than 4 years old) with Type I diabetes when they are initiated on insulin pump therapy.

详细描述

A randomized controlled clinical trial involving patients 0-3 yrs old with type 1 diabetes. After successful screening the subjects will be randomized into one of two groups: a CSII group alone and a CSII group + Real Time Sensor Augmentation group (RTSA) group. The CSII group will serve as the control for the CSII+RTSA group. The trial will last for one year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Months 至 3 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children less than 4 years of age with Type I diabetes for at least 3 months

排除标准

  • Children greater than 4 years of age
  • Monogenic diabetes

结局指标

主要结局

Reduce blood glucose variability among 0-3 year old children with type I diabetes.

时间窗: 1 year

次要结局

  • Number of adverse events(1 year)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验